Suppr超能文献

子宫上皮样平滑肌肉瘤:大型机构系列中基于现代结果的诊断标准评估

Epithelioid Leiomyosarcoma of the Uterus: Modern Outcome-based Appraisal of Diagnostic Criteria in a Large Institutional Series.

作者信息

Chapel David B, Nucci Marisa R, Quade Bradley J, Parra-Herran Carlos

机构信息

Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital-Harvard Medical School, Boston, MA.

Department of Pathology, University of Michigan-Michigan Medicine, Ann Arbor, MI.

出版信息

Am J Surg Pathol. 2022 Apr 1;46(4):464-475. doi: 10.1097/PAS.0000000000001795.

Abstract

Epithelioid leiomyosarcoma of the uterus is rare and poorly understood. Herein, we characterize a large institutional series of epithelioid leiomyosarcomas aiming to define outcome-determinant diagnostic pathologic features. We also retrieved epithelioid smooth muscle tumors of unknown malignant potential and evaluated a consecutive cohort of leiomyomas for epithelioid subtypes. Of a total of 1177 uterine leiomyosarcomas, 81 (7%) were categorized as epithelioid after review. Epithelioid leiomyosarcoma was strictly defined as having round to polygonal cells with visible pink cytoplasm and round to ovoid nuclei in ≥50% of the tumor volume. Average age was 55 years (range: 26 to 81 y). Median tumor size was 11 cm; tumor was >5 cm in 93% of subjects; 47% were stage 1 at presentation. An infiltrative tumor border was observed, grossly and/or microscopically, in 89% of cases; necrosis was noted in 80%, and vascular invasion in 47%. Mitotic count in 2.4 mm2 (totalling 10 high-power fields, each field 0.55 mm in diameter) ranged from 3 to 100 (median: 26). All cases had moderate, severe or highly pleomorphic atypia. All cases had 2 or 3 of the following: necrosis, at least moderate atypia and ≥4 mitoses in 2.4 mm2. Immunohistochemistry revealed frequent expression of smooth muscle markers including SMA (96%), desmin (95%), and caldesmon (81%). HMB45 and Melan-A were negative in 92% and 100% of cases, respectively. Estrogen and progesterone receptors were expressed by 65% and 54% of tumors, respectively. Follow-up information was available in 68 subjects (median: 23 mo, range: 1 to 254); cancer-related death occurred in 63%, and an additional 15% had recurrent or metastatic disease at last follow-up. Disease-specific survival was shorter in epithelioid leiomyosarcoma patients (median: 44  mo; 35% at 5-y) than in a matched cohort of nonepithelioid leiomyosarcoma (median: 55 mo; 46% at 5-y) (P=0.03). Three epithelioid smooth muscle tumors of unknown malignant potential were evaluated, all <5 cm in size and with atypia and/or irregular borders but mitotic count below the threshold for malignancy. Two of these had follow-up available, which was uneventful. Of 142 consecutive leiomyomas assessed, none had epithelioid morphology as defined. Epithelioid leiomyosarcoma is an aggressive neoplasm, sometimes with a remarkably low mitotic count. In the setting of an epithelioid smooth muscle tumor of the uterus, we postulate that the diagnosis of malignancy is made in the presence of ≥2 of the following: moderate or severe atypia, ≥4 mitoses/2.4 mm2 and tumor cell necrosis. In their absence, the finding of tumor size ≥5 cm, vascular invasion, infiltrative edges or atypical mitoses should be treated with caution, and designation as of at least uncertain malignant potential is warranted.

摘要

子宫上皮样平滑肌肉瘤罕见且了解甚少。在此,我们对大量来自机构的上皮样平滑肌肉瘤病例进行特征分析,旨在明确决定预后的诊断性病理特征。我们还检索了具有未知恶性潜能的上皮样平滑肌肿瘤,并评估了一组连续的平滑肌瘤中的上皮样亚型。在总共1177例子宫平滑肌肉瘤中,经复查后有81例(7%)被归类为上皮样。上皮样平滑肌肉瘤被严格定义为在肿瘤体积的≥50%中具有圆形至多边形细胞,细胞质可见粉红色,核圆形至卵圆形。平均年龄为55岁(范围:26至81岁)。肿瘤中位数大小为11cm;93%的患者肿瘤>5cm;47%的患者初诊时为1期。89%的病例在大体和/或显微镜下观察到浸润性肿瘤边界;80%的病例有坏死,47%的病例有血管侵犯。每2.4mm²(总计10个高倍视野,每个视野直径0.55mm)的有丝分裂计数范围为3至100(中位数:26)。所有病例均有中度、重度或高度多形性异型性。所有病例均具备以下2项或3项:坏死、至少中度异型性以及每2.4mm²≥4个有丝分裂。免疫组化显示平滑肌标志物频繁表达,包括平滑肌肌动蛋白(SMA,96%)、结蛋白(95%)和钙调蛋白(81%)。HMB45和Melan - A分别在92%和100%的病例中呈阴性。65%的肿瘤表达雌激素受体,54%的肿瘤表达孕激素受体。68例患者有随访信息(中位数:23个月,范围:1至254个月);63%的患者发生癌症相关死亡,另有15%的患者在最后随访时出现复发或转移性疾病。上皮样平滑肌肉瘤患者的疾病特异性生存期较短(中位数:44个月;5年生存率35%),低于匹配的非上皮样平滑肌肉瘤队列(中位数:55个月;5年生存率46%)(P = 0.03)。评估了3例具有未知恶性潜能的上皮样平滑肌肿瘤,所有肿瘤大小均<5cm,有异型性和/或边界不规则,但有丝分裂计数低于恶性阈值。其中2例有随访信息,情况良好。在评估的142例连续平滑肌瘤中,无一例具有定义的上皮样形态。上皮样平滑肌肉瘤是一种侵袭性肿瘤,有时有丝分裂计数极低。对于子宫上皮样平滑肌肿瘤,我们推测在具备以下≥2项时可诊断为恶性:中度或重度异型性、每2.4mm²≥4个有丝分裂以及肿瘤细胞坏死。若不存在这些情况,对于肿瘤大小≥5cm、血管侵犯、浸润性边缘或非典型有丝分裂的发现应谨慎对待,至少指定为具有不确定的恶性潜能是合理的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验